BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
FXYD4
,
Metabolism of xenobiotics
,
Hepatitis
,
Stem cell
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ror1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
ROR1-regulated gene expression in MDA-MB-231 breast cancer cells
Breast cancer patient-derived xenografts from mice treated with anti-ROR1 antibody cirmtuzumab
Explore Curated Studies Results
Literature
Most Relevant Literature
Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosin…
Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell en…
ROR1 expression in mature B lymphoid neoplasms by flow cytometry.
Quantitative Investigation of Neuroprotective Role of ROR1 in a Cell Culture Model of Alzheimer's Di…
Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
First in Human Study of NVG-111 in Chronic Lymphocytic Leukaemia and Mantle Cell Lymphoma
UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia
Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previ…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ